A secure pharma supply chain starts with innovation, interoperability and collaboration.

Earlier this year, the FDA called on the life sciences and healthcare industry to design and deliver pilot projects for an electronic, interoperable system that can identify and trace prescription drugs as they are distributed across the United States in support of the DSCSA. Several industry innovators including Systech, RxTransparent, T-Systems, FarmaTrust, CryptoWerk and CalQLogic responded to the FDA’s proposal.

In this 45-minute webinar, you’ll learn about the future of US drug supply chain management, including:

  • The challenges that need to be overcome
  • How technology like digital e-Fingerprinting®, IOT Cold Chain data and Blockchain can be leveraged
  • The benefits of a collaborative approach to ongoing supply chain issues

Date | On-Demand
Duration | 45 Minutes

Watch "Understanding the FDA's New Pilot Program: The Future of the Drug Supply Chain"

Panelists Bios

bob-celesteBob Celeste
[Moderator]
Center for Supply Chain Studies

peter-bryantPeter Bryant
COO
FarmaTrust

dwight-devereDwight deVera
CEO
The Forerunner Group / RxTransparent

peter-ebertPeter Ebert
SVP Sales and Business Development
Cryptowerk

joe-lipariJoe Lipari
Director of Cloud Products
Systech

swamy-narayanaswamySwamy Narayanaswamy
CTO and Co-Founder
CalQLogic, Inc.

james-sabogalJames Sabogal
Head of Healthcare/Life Sciences
T-Systems


Originally aired April 30, 2019